Shifting the focus of tuberculosis research in India

Tuberculosis

Volumn 83, Issue 1-3, 2003, Pages 135-142

  Narayanan, P R ^a   Garg, Renu ^b   Santha, T ^a   Kumaran, P Paul ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

BACTERIUM DETECTION; BCG VACCINATION; BODY BURDEN; CHEMOTHERAPY; CLINICAL OBSERVATION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG SAFETY; EVALUATION; FEASIBILITY STUDY; FUNCTIONAL ASSESSMENT; GENDER; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MANAGEMENT; MEDICAL RESEARCH; MULTIDRUG RESISTANCE; PATIENT MONITORING; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RISK FACTOR; SHORT COURSE THERAPY; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; SYSTEM ANALYSIS; TUBERCULOSIS CONTROL; UPREGULATION;

EID: 0037844341     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(02)00068-9     Document Type: Conference Paper

References (26)

1. Indian Council of Medical Research. Tuberculosis in India: a sample survey, 1955-58. Special Report Series No. 34. New Delhi, India: ICMR, 1959: p. 1-121.
2. Tuberculosis Chemotherapy Centre, Madras. A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Bull World Health Organ 1959;21:51-144.
3. Fox W. The problem of self-administration of drugs, with particular reference to pulmonary tuberculosis. Tubercle 1958;39:269-74.
4. Bannerji D, Andersen S. A sociological study of awareness of symptoms among persons with pulmonary tuberculosis. Bull World Health Organ 1963;29:665-83.
5. Baily GVJ, Savic D, Gothi GD, Naidu VB, Nair SS. Potential yield of pulmonary tuberculosis by direct microscopy of sputum in a district of South India. Bull World Health Organ 1967;37:875-92.
6. Nagpaul DR. District Tuberculosis Control Programme in concept and outline. Indian J Tuberc 1967;14:186-98.
7. Tuberculosis Chemotherapy Centre, Madras. A concurrent comparison of intermittent (twice weekly) isoniazid plus streptomycin and daily isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis. Bull World Health Organ 1964;31:247-71.
8. Santha T, Nazareth O, Krishnamurthy MS, Balasubramanian R, Vijayan VK, Janardhanam B, Venkataraman P, Tripathy SP, Prabhakar R. Treatment of pulmonary tuberculosis with short course chemotherapy in South India - 5-year follow-up. Tubercle 1989;70:229-34.
9. Balasubramanium R. Fully intermittent 6 months regimen for pulmonary tuberculosis in South India. Indian J Tuberc 1991;38:51-3.
10. Tuberculosis Research Centre, Madras and National Tuberculosis Institute, Bangalore. A controlled clinical trial of 3- and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in South India. Am Rev Respir Dis 1986;134:27-33.
11. World Health Organization 1992. Programme Review India. WHO/TB/95.186
12. Khatri GR, Frieden TR. The status and prospects of tuberculosis control in India. Int J Tuberc Lung Dis 2000;4:193-200.
13. CDC. Progress towards tuberculosis control, India, 2001. MMWR 2002;77:89-93.
14. Government of India. Health Information of India. New Delhi: Central Bureau of Health Intelligence, Directorate General of Health Services, Government of India, New Delhi, 1993.
15. Uplekar MW, Rangan S. Private doctors and tuberculosis control in India. Tuberc Lung Dis 1993;74:332-7.
16. Uplekar MW, Shepard DS. Treatment of tubercutosis by private general practitioners in India. Tubercle 1991;72:284-90.
17. Rajeshwari R, Balasubramanian R, Bose MSC, Sekar L, Rehman F. Private pharmacies in tuberculosis control - a neglected link. Int J Tuberc Lung Dis 2002;6:171-3.
18. World Health Organization 2001. Involving private practitioners in tuberculosis control: Issues, interventions, and emerging policy framework. WHO/CDC/TB/2001.285.
19. Central Tuberculosis Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Government of India 2001, New Delhi, Network Programme India. March 21, 2002. www.tbcindia.org.
20. Santha T, Garg R, Frieden TR, et al. Risk factors associated with default, failure, and death among tuberculosis patients treated in a DOTS program in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 2002;6(9):780-8.
21. Tuberculosis Research Centre, Chennai. Shortening short course chemotherapy: a randomized clinical trial for treatment of smear positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase. Indian J Tuberc 2002;49:27-38.
22. Rajeswari R, Chandrasekaran V, Suhadev M, Sivasubramaniam S, Sudha G, Renu G. Factors associated with patient and health system delays in the diagnosis of tuberculosis-South India. Int J Tuberc Lung Dis 2002;6(9):789-95.
23. DeCock KM, Weiss HA. The global epidemiology of HIV/AIDS. Trop Med Int Health 2000;5:A3-9.
24. Swaminathan S, Ramachandran R, Baskaran G, et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2000;4:839-44.
25. Paramasivan CN, Bhaskaran K, Venkataraman P, Chandrasekharan V, Narayanan PR. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuberc 2000;47:27-34.
26. Nair VM, Thankappan KR, Sarma PS, Vasan RS. Changing role of grass-root level health workers in Kerala, India. Health Policy Planning 2002;16:171-9.